Cargando…
Cytotoxic chemotherapy is associated with decreased bone mineral density in postmenopausal women with early and locally advanced breast cancer
PURPOSE: The burden and mechanisms of endocrine therapy-related bone loss have been studied in detail. However, there is limited data regarding cytotoxic chemotherapy’s impact on bone health. There are no definitive guidelines for bone mineral density (BMD) monitoring and treatment with bone-modifyi...
Autores principales: | Nisha, Yadav, Dubashi, Biswajit, Bobby, Zachariah, Sahoo, Jaya Prakash, Kayal, Smita, Ananthakrishnan, Ramesh, Ganesan, Prasanth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004442/ https://www.ncbi.nlm.nih.gov/pubmed/36899284 http://dx.doi.org/10.1007/s11657-023-01231-z |
Ejemplares similares
-
Efficacy and safety of pomalidomide, bortezomib, and dexamethasone combination chemotherapy for newly diagnosed multiple myeloma: POMACE Phase II Study
por: Saj, Fen, et al.
Publicado: (2023) -
P909: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE CHEMOTHERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: POMACE PHASE II STUDY
por: Saj, Fen, et al.
Publicado: (2023) -
Baricitinib: Two Birds with One Stone
por: Saj, Fen, et al.
Publicado: (2022) -
Poster: ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study
por: Anandaradje, Annuja, et al.
Publicado: (2021) -
ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study
por: Anandaradje, Annuja, et al.
Publicado: (2021)